Crossmark

Clinical experience of prophylactic enoxaparin dosage adjustment guided by AntiXa factor levels in critical care patients with COVID-19-induced pneumonia: observational study

Crossref DOI link: https://doi.org/10.1016/j.medine.2023.05.009

Published Print: 2023-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Bermúdez-Ruiz, María del Carmen

Vilar Sánchez, Irene

Aparicio Pérez, Clara

Carmona Flores, Rosario

Rodríguez-Gómez, Jorge

de la Fuente-Martos, Carmen
License Information

Text and Data Mining valid from 2023-08-01

Version of Record valid from 2023-07-18
More Information

This article is maintained by: Elsevier

Article Title: Clinical experience of prophylactic enoxaparin dosage adjustment guided by AntiXa factor levels in critical care patients with COVID-19-induced pneumonia: observational study

Journal Title: Medicina Intensiva (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medine.2023.05.009

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medin.2023.04.012

Content Type: article

Copyright: © 2023 The Authors. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below